De Motu Cordis

    OverviewSuggest Edit

    De Motu Cordis (DMC) is a pharmaceutical and medical device company. It is engaged in the commercial development of drug-device combination products for drug delivery in emergency indications including cardiac arrest and anaphylaxis.

    Latest Updates

    Employees (est.) (Nov 2021)8(+15%)
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at De Motu Cordis

    John F Fraser

    John F Fraser

    Founder and Chairman
    Sonia Barber

    Sonia Barber

    Non-Executive Director
    Show more

    De Motu Cordis Financials and Metrics

    Summary Metrics

    Founding Date


    De Motu Cordis Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    De Motu Cordis Online and Social Media Presence

    Embed Graph

    De Motu Cordis Frequently Asked Questions

    • When was De Motu Cordis founded?

      De Motu Cordis was founded in 2015.

    • Who are De Motu Cordis key executives?

      De Motu Cordis's key executives are John F Fraser and Sonia Barber.

    • How many employees does De Motu Cordis have?

      De Motu Cordis has 8 employees.

    • Who are De Motu Cordis competitors?

      Competitors of De Motu Cordis include iVeena, PhaseBio Pharmaceuticals and JETEMA.